The latest cancer drugs news
Browsing: Cancer Drug News
Diazonamide holds promise as cancer treatment with fewer side effects
A synthetic version of a rare toxin produced by a sea creature appears to hold…
Tiny barcodes provide huge advance in personalised cancer therapy
Using synthetic DNA sequences as the tiniest of barcodes, Technion researchers have developed a new…
Phase III nivolumab trial shows overall survival benefit for advanced gastric cancer
A phase clinical trial evaluating the efficacy and safety of nivolumab (marketed as Opdivo by Bristol…
How an old antidepressant could provide the next brain cancer breakthrough
By Geoff Pilkington, University of Portsmouth. In 1998, I received an intriguing handwritten note. It came…
New drug combination could target incurable infant cancer
Scientists have identified a drug combination that could be effective against a childhood cancer for…
Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours
More than ten years of published clinical data and personal experience using peptide receptor radionuclide…
Propanolol as an anti-cancer drug
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant…
Breast cancer resistance to tamoxifen elucidated
Researchers have discovered that a protein found naturally in cells that provides some protection from…
ESMO 2016: Longer disease-free survival in phase III trial of sunitinib as adjuvant treatment for kidney cancer
A phase III trial of sunitinib has met its primary endpoint of disease-free survival for…
ESMO 2016: Niraparib significantly improves outcome of ovarian cancer patients in landmark trial
The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to…